24HourWire
News from all angles
MedPage Today
Center
Another Win for Novel Drug, This Time in EGFR-Mutated Lung Cancer
(MedPage Today) -- A first-in-class bispecific antibody-drug conjugate (ADC) nearly doubled progression-free survival (PFS) compared with chemotherapy in patients with EGFR-mutated advanced non-small…